The European Medicines Agency (EMEA) has a role to play in this empowerment of patients and consumers. As the European Union's official body for the evaluation and supervision of medicines, the EMEA has a wealth of information to share with patients and consumers about the latest developments in this field. The Agency makes this information freely accessible to support and encourage widespread public understanding of medicines and their use.

The EMEA is a unique forum for new thinking on the future direction of medicines regulation in Europe. The EMEA welcomes and actively seeks contributions to these efforts from the people whom legislation affects most, namely patients, doctors and pharmaceutical companies. As part of this commitment to open debate with its stakeholders, the Agency has created a number of mechanisms for the active participation of patients and consumers in its activities.

This section of the EMEA website is devoted to providing a practical overview of the types of information that are of greatest interest to patients and consumers, as well as of the opportunities created for their participation in the Agency's activities.

By providing clear, authoritative and up-to-date information on matters that are of direct or indirect interest to them, the EMEA aims to contribute to the empowerment of patients and consumers through information and participation.

Link:
http://emea.europa.eu/Patients/introduction.htm